December 11, 2014
First generic versions of the anticancer drug Elplat (oxaliplatin) and the acute lung injury treatment Elaspol (sivelestat sodium hydrate) will join the NHI price listing on December 12, according to the Ministry of Health, Labor and Welfare. The ministry said...read more